# Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes

> **NCT01580813** · NA · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 13 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Acipimox
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01580813
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2015-06-05
- **Final completion:** 2015-06-05
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2021-12-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01580813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01580813, "Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01580813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*